Trial intelligence / Profile preview

Equetro Once vs Twice Daily in Bipolar Mania

NCT00150553Phase 3Completed

Sponsor
Validus Pharmaceuticals
Start
Jan 2005
Modality
Small Molecules
01

Overview

A Phase 3 trial of carbamazepine in bipolar I disorder, sponsored by Validus Pharmaceuticals. Started Jan 2005; status: completed.

02

Drugs

carbamazepine
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on NCT00150553.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00150553.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call